Edna Bonhomme

A judge in Georgia recently struck down the six-week abortion ban. But total or near-total bans are still in place in sixteen other states. Florida, where I grew up, enacted a six-week ban in May. ‘We don’t want to be an abortion tourism destination,’ Governor Ron DeSantis said.

‘My My Metrocard’ by Le Tigre (1999) is a raucous hymn to the New York subway and an attack on the then mayor’s much vaunted efforts to ‘clean up’ the city: ‘oh fuck Giuliani/…/next stop Atlantic Avenue’. The song came to mind when I was in New York towards the end of last year and every subway station was saturated with the NYPD. The current mayor, Eric Adams, had announced plans to ‘target transit crime’ and further criminalise homelessness.

In late July, the World Health Organisation declared monkeypox a public health emergency of international concern. Since May, there have been more than 22,000 confirmed cases in nearly eighty countries around the world, of which more than 13,000 have been in Europe. The countries with the highest numbers of confirmed cases are Spain, the US, Germany and the UK. Last week Spain reported two deaths linked to monkeypox. Although the virus can spread to anyone, 98 per cent of confirmed cases are men who have sex with men (MSM), strongly suggesting that sexual contact is the primary mode of transmission of these new infections.

The leaked Supreme Court draft opinion that threatens to overturn Roe v. Wade concerns the case of Dobbs v. Jackson Women’s Health Organisation, a 2018 Mississippi state law that bans abortions after the first fifteen weeks of pregnancy. If Roe v. Wade is overturned, then the Jackson Women’s Health Organisation – the last remaining abortion clinic in the state of Mississippi – will have to close its doors. Most of its patients are African American and working-class women.

A 2013 study found that ‘diseases of relevance to high-income countries were investigated in clinical trials seven to eight times more often than were diseases whose burden lies mainly in low-income and middle-income countries.’ The NEJM reported in 2009 that pharmaceutical companies were conducting more clinical trials in developing countries, yet ‘among the ongoing phase 3 clinical trials that we examined that were sponsored by US-based companies in developing countries, none were trials of diseases such as tuberculosis that disproportionately affect the populations of these countries.’ Of more than 1500 new drugs produced between 1975 and 2004, only 21 targeted malaria, tuberculosis and other neglected diseases that are most common in low-income countries.